Medicare claims analyses offer insight into how proposed policy changes would affect out-of-pocket prescription costs for Part D beneficiaries requiring specialty drugs.
Ashley Flint, MPP
Advertisement
Articles by Ashley Flint, MPP
Advertisement
Latest Updated Articles
- Reducing Out-of-Pocket Cost Barriers to Specialty Drug Use Under Medicare Part D: Addressing the Problem of "Too Much Too Soon"
Published: March 17th 2017 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
Pulling Back Funding for Research COuld Leave HIV Treatment in Worse State: Patrick Sullivan, DVM, PhD
3
HMA Combination Therapy Boosts Survival in Accelerated- or Blast-Phase MPNs
4
Value-Based Care Interventions and Management of CKD Progression
5
